120 related articles for article (PubMed ID: 38560969)
1. Predicting Stage Progression in Binet Stage a Chronic Lymphocytic Leukemia.
Alshemmari SH; Almazyad M; Alsarraf A; Kunhikrishnan A; Isaac AM; Kaempf A
Hematol Oncol Stem Cell Ther; 2024 Mar; 17(2):137-145. PubMed ID: 38560969
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Alternative International Prognostic Score-E (AIPS-E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocol.
Morabito F; Tripepi G; Vigna E; Bossio S; D'Arrigo G; Martino EA; Storino F; Recchia AG; Fronza G; Di Raimondo F; Colombo M; Fais F; Neri A; Cutrona G; Ferrarini M; Gentile M
Eur J Haematol; 2021 Jun; 106(6):831-835. PubMed ID: 33662164
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of four prognostic scoring system in patients with early asymptomatic chronic lymphocytic leukemia patients].
Sha YQ; Shen H; Wu W; Xia Y; Miao Y; Cao L; Wang L; Fan L; Xu W; Li JY; Zhu HY
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):834-839. PubMed ID: 34788923
[No Abstract] [Full Text] [Related]
4. International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.
Condoluci A; Terzi di Bergamo L; Langerbeins P; Hoechstetter MA; Herling CD; De Paoli L; Delgado J; Rabe KG; Gentile M; Doubek M; Mauro FR; Chiodin G; Mattsson M; Bahlo J; Cutrona G; Kotaskova J; Deambrogi C; Smedby KE; Spina V; Bruscaggin A; Wu W; Moia R; Bianchi E; Gerber B; Zucca E; Gillessen S; Ghielmini M; Cavalli F; Stussi G; Hess MA; Baumann TS; Neri A; Ferrarini M; Rosenquist R; Forconi F; Foà R; Pospisilova S; Morabito F; Stilgenbauer S; Döhner H; Parikh SA; Wierda WG; Montserrat E; Gaidano G; Hallek M; Rossi D
Blood; 2020 May; 135(21):1859-1869. PubMed ID: 32267500
[TBL] [Abstract][Full Text] [Related]
5. IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.
Bulian P; Rossi D; Forconi F; Del Poeta G; Bertoni F; Zucca E; Montillo M; Pozzato G; D'Arena G; Efremov DG; Marasca R; Lauria F; Gaidano G; Gattei V; Laurenti L
J Transl Med; 2012 Jan; 10():18. PubMed ID: 22289136
[TBL] [Abstract][Full Text] [Related]
6. External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score.
Smolej L; Turcsányi P; Kubová Z; Zuchnická J; Mihályová J; Šimkovič M; Vodárek P; Krčméryová M; Móciková H; Brejcha M; Špaček M;
Br J Haematol; 2021 Apr; 193(1):133-137. PubMed ID: 33280081
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the CLL-IPI and IPS-E Prognostic Indices in a Young Middle Eastern Population with Chronic Lymphocytic Leukemia: A Retrospective Analysis at the Kuwait Cancer Control Center.
Alshemmari SH; Alsarraf A; Kunhikrishnan A; Pandita R
Med Princ Pract; 2023; 32(3):192-199. PubMed ID: 37517397
[TBL] [Abstract][Full Text] [Related]
8. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.
Delgado J; Doubek M; Baumann T; Kotaskova J; Molica S; Mozas P; Rivas-Delgado A; Morabito F; Pospisilova S; Montserrat E
Am J Hematol; 2017 Apr; 92(4):375-380. PubMed ID: 28120419
[TBL] [Abstract][Full Text] [Related]
10. The importance of IGHV mutational status in del(11q) and del(17p) chronic lymphocytic leukemia.
Gladstone DE; Blackford A; Cho E; Swinnen L; Kasamon Y; Gocke CD; Griffin CA; Bolaños-Meade J; Jones RJ
Clin Lymphoma Myeloma Leuk; 2012 Apr; 12(2):132-7. PubMed ID: 22285608
[TBL] [Abstract][Full Text] [Related]
11. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
International CLL-IPI working group
Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642
[TBL] [Abstract][Full Text] [Related]
12. Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?
Brieghel C; Galle V; Agius R; da Cunha-Bang C; Andersen MA; Vlummens P; Mattsson M; Rosenquist R; Smedby KE; Herling CD; Bahlo J; Hallek M; Lundgren JD; Offner F; Niemann CU
Eur J Haematol; 2022 May; 108(5):369-378. PubMed ID: 35030282
[TBL] [Abstract][Full Text] [Related]
13. Multivariable model consisting of clinical and biological markers for time to first treatment in CLL patients: Preliminary results from single centre experience.
Trajkova S; Cevreska L; Pivkova-Veljanovska A; Ivanovski M; Dukovski D; Popova-Simjanovska M; Cadievski L; Eftimov A; Dimovski A; Panovska-Stavridis I
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(3):39-47. PubMed ID: 24566014
[TBL] [Abstract][Full Text] [Related]
14. Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group.
Hoechstetter MA; Busch R; Eichhorst B; Bühler A; Winkler D; Bahlo J; Robrecht S; Eckart MJ; Vehling-Kaiser U; Jacobs G; Jäger U; Hurtz HJ; Hopfinger G; Hartmann F; Fuss H; Abenhardt W; Blau I; Freier W; Müller L; Goebeler M; Wendtner C; Fischer K; Herling CD; Starck M; Bentz M; Emmerich B; Döhner H; Stilgenbauer S; Hallek M
Leukemia; 2020 Apr; 34(4):1038-1051. PubMed ID: 32042081
[TBL] [Abstract][Full Text] [Related]
15. Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome.
Tobin G; Thunberg U; Laurell A; Karlsson K; Aleskog A; Willander K; Söderberg O; Merup M; Vilpo J; Hultdin M; Sundström C; Roos G; Rosenquist R
Haematologica; 2005 Apr; 90(4):465-9. PubMed ID: 15820941
[TBL] [Abstract][Full Text] [Related]
16. Multivariable model for time to first treatment in patients with chronic lymphocytic leukemia.
Wierda WG; O'Brien S; Wang X; Faderl S; Ferrajoli A; Do KA; Garcia-Manero G; Cortes J; Thomas D; Koller CA; Burger JA; Lerner S; Schlette E; Abruzzo L; Kantarjian HM; Keating MJ
J Clin Oncol; 2011 Nov; 29(31):4088-95. PubMed ID: 21969505
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic significance of CLL-IPI for Chinese patients with chronic lymphocytic leukemia].
Zhu HY; Wang L; Qiao J; Zou YX; Xia Y; Wu W; Cao L; Liang JH; Fan L; Xu W; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2018 May; 39(5):392-397. PubMed ID: 29779348
[No Abstract] [Full Text] [Related]
18. Clinical features and outcome of Chinese patients with monoclonal B-cell lymphocytosis.
Xu W; Li JY; Wu YJ; Cao X; Fan L; Qiao C; Liu Q; Yao L; Miao KR
Leuk Res; 2009 Dec; 33(12):1619-22. PubMed ID: 19250675
[TBL] [Abstract][Full Text] [Related]
19. The signs of negative selection in IGHV framework regions are associated with worse overall survival of chronic lymphocytic leukemia patients.
Abramenko I; Bilous N; Chumak A; Kryachok I; Fedorenko Z; Martina Z; Dyagil I
Leuk Res; 2021 Nov; 110():106686. PubMed ID: 34492598
[TBL] [Abstract][Full Text] [Related]
20. Chronic lymphocytic leukemia in a young population.
Alshemmari SH; Hamdah A; Pandita R; Kunhikrishnan A
Leuk Res; 2021 Nov; 110():106668. PubMed ID: 34492597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]